35Pharma

Montreal, Canada · Founded 2021 · Acquired/Merged (Operating Subsidiary)

Operator of a biopharmaceutical company intended for pulmonary hypertension and musculoskeletal disorders. 35Pharma is based in Montreal, Canada and was founded in 2021. Its last known valuation is $950 million (Apr 2026). It has raised $70 million.

Last price · $/share

—

Implied valuation

$950.0M

Total raised

$70.0M

Last round

—

How much has 35Pharma raised?

$70.0Macross 0 recorded rounds

Free account

More of 35Pharma with a free account

·Watch 35Pharma: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

35Pharma investors

10 investors are on record for 35Pharma, including Logos Capital, Frazier Healthcare Partners, Marshall Wace and Vivo Capital. By type, the record holds 4 venture capital firms, 4 hedge funds and 1 asset manager.

For fundraisers

Raising for a company like 35Pharma?

10 investors have backed 35Pharma.

See all 10 investors →

Frequently asked about 35Pharma

How much has 35Pharma raised?: 35Pharma has raised $70.0M in total across 0 recorded funding rounds.